The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hematopoietic Stem Cell Transplantation (HSCT)-Global Market Insights and Sales Trends 2024
Synopsis
The global Hematopoietic Stem Cell Transplantation (HSCT) market size is expected to reach US$ 3579.5 million by 2029, growing at a CAGR of 5.7% from 2023 to 2029. The market is mainly driven by the significant applications of Hematopoietic Stem Cell Transplantation (HSCT) in various end use industries. The expanding demands from the Peripheral Blood Stem Cells Transplant (PBSCT), Bone Marrow Transplant (BMT) and Cord Blood Transplant (CBT),, are propelling Hematopoietic Stem Cell Transplantation (HSCT) market. Allogeneic, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Autologous segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hematopoietic Stem Cell Transplantation (HSCT), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hematopoietic Stem Cell Transplantation (HSCT) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hematopoietic Stem Cell Transplantation (HSCT) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hematopoietic Stem Cell Transplantation (HSCT) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hematopoietic Stem Cell Transplantation (HSCT) covered in this report include Regen Biopharma Inc, China Cord Blood Corp, CBR Systems Inc, Escape Therapeutics Inc, Cryo-Save AG, Lonza Group Ltd, Pluristem Therapeutics Inc and ViaCord Inc, etc.
The global Hematopoietic Stem Cell Transplantation (HSCT) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Regen Biopharma Inc
China Cord Blood Corp
CBR Systems Inc
Escape Therapeutics Inc
Cryo-Save AG
Lonza Group Ltd
Pluristem Therapeutics Inc
ViaCord Inc
Global Hematopoietic Stem Cell Transplantation (HSCT) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hematopoietic Stem Cell Transplantation (HSCT) market, Segment by Type:
Allogeneic
Autologous
Global Hematopoietic Stem Cell Transplantation (HSCT) market, by Application
Peripheral Blood Stem Cells Transplant (PBSCT)
Bone Marrow Transplant (BMT)
Cord Blood Transplant (CBT)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hematopoietic Stem Cell Transplantation (HSCT) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Hematopoietic Stem Cell Transplantation (HSCT) market size is expected to reach US$ 3579.5 million by 2029, growing at a CAGR of 5.7% from 2023 to 2029. The market is mainly driven by the significant applications of Hematopoietic Stem Cell Transplantation (HSCT) in various end use industries. The expanding demands from the Peripheral Blood Stem Cells Transplant (PBSCT), Bone Marrow Transplant (BMT) and Cord Blood Transplant (CBT),, are propelling Hematopoietic Stem Cell Transplantation (HSCT) market. Allogeneic, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Autologous segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hematopoietic Stem Cell Transplantation (HSCT), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hematopoietic Stem Cell Transplantation (HSCT) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hematopoietic Stem Cell Transplantation (HSCT) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hematopoietic Stem Cell Transplantation (HSCT) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hematopoietic Stem Cell Transplantation (HSCT) covered in this report include Regen Biopharma Inc, China Cord Blood Corp, CBR Systems Inc, Escape Therapeutics Inc, Cryo-Save AG, Lonza Group Ltd, Pluristem Therapeutics Inc and ViaCord Inc, etc.
The global Hematopoietic Stem Cell Transplantation (HSCT) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Regen Biopharma Inc
China Cord Blood Corp
CBR Systems Inc
Escape Therapeutics Inc
Cryo-Save AG
Lonza Group Ltd
Pluristem Therapeutics Inc
ViaCord Inc
Global Hematopoietic Stem Cell Transplantation (HSCT) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hematopoietic Stem Cell Transplantation (HSCT) market, Segment by Type:
Allogeneic
Autologous
Global Hematopoietic Stem Cell Transplantation (HSCT) market, by Application
Peripheral Blood Stem Cells Transplant (PBSCT)
Bone Marrow Transplant (BMT)
Cord Blood Transplant (CBT)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Hematopoietic Stem Cell Transplantation (HSCT) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Hematopoietic Stem Cell Transplantation (HSCT)
1.1 Hematopoietic Stem Cell Transplantation (HSCT) Market Overview
1.1.1 Hematopoietic Stem Cell Transplantation (HSCT) Product Scope
1.1.2 Hematopoietic Stem Cell Transplantation (HSCT) Market Status and Outlook
1.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size by Region (2018-2029)
1.4 Global Hematopoietic Stem Cell Transplantation (HSCT) Historic Market Size by Region (2018-2023)
1.5 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Hematopoietic Stem Cell Transplantation (HSCT) Market Size (2018-2029)
1.6.1 North America Hematopoietic Stem Cell Transplantation (HSCT) Market Size (2018-2029)
1.6.2 Europe Hematopoietic Stem Cell Transplantation (HSCT) Market Size (2018-2029)
1.6.3 Asia-Pacific Hematopoietic Stem Cell Transplantation (HSCT) Market Size (2018-2029)
1.6.4 Latin America Hematopoietic Stem Cell Transplantation (HSCT) Market Size (2018-2029)
1.6.5 Middle East & Africa Hematopoietic Stem Cell Transplantation (HSCT) Market Size (2018-2029)
2 Hematopoietic Stem Cell Transplantation (HSCT) Market by Type
2.1 Introduction
2.1.1 Allogeneic
2.1.2 Autologous
2.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Historic Market Size by Type (2018-2023)
2.2.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue Breakdown by Type (2018-2029)
3 Hematopoietic Stem Cell Transplantation (HSCT) Market Overview by Application
3.1 Introduction
3.1.1 Peripheral Blood Stem Cells Transplant (PBSCT)
3.1.2 Bone Marrow Transplant (BMT)
3.1.3 Cord Blood Transplant (CBT)
3.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Historic Market Size by Application (2018-2023)
3.2.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue Breakdown by Application (2018-2029)
4 Hematopoietic Stem Cell Transplantation (HSCT) Competition Analysis by Players
4.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hematopoietic Stem Cell Transplantation (HSCT) as of 2022)
4.3 Date of Key Players Enter into Hematopoietic Stem Cell Transplantation (HSCT) Market
4.4 Global Top Players Hematopoietic Stem Cell Transplantation (HSCT) Headquarters and Area Served
4.5 Key Players Hematopoietic Stem Cell Transplantation (HSCT) Product Solution and Service
4.6 Competitive Status
4.6.1 Hematopoietic Stem Cell Transplantation (HSCT) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Regen Biopharma Inc
5.1.1 Regen Biopharma Inc Profile
5.1.2 Regen Biopharma Inc Main Business
5.1.3 Regen Biopharma Inc Hematopoietic Stem Cell Transplantation (HSCT) Products, Services and Solutions
5.1.4 Regen Biopharma Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue (US$ Million) & (2018-2023)
5.1.5 Regen Biopharma Inc Recent Developments
5.2 China Cord Blood Corp
5.2.1 China Cord Blood Corp Profile
5.2.2 China Cord Blood Corp Main Business
5.2.3 China Cord Blood Corp Hematopoietic Stem Cell Transplantation (HSCT) Products, Services and Solutions
5.2.4 China Cord Blood Corp Hematopoietic Stem Cell Transplantation (HSCT) Revenue (US$ Million) & (2018-2023)
5.2.5 China Cord Blood Corp Recent Developments
5.3 CBR Systems Inc
5.3.1 CBR Systems Inc Profile
5.3.2 CBR Systems Inc Main Business
5.3.3 CBR Systems Inc Hematopoietic Stem Cell Transplantation (HSCT) Products, Services and Solutions
5.3.4 CBR Systems Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue (US$ Million) & (2018-2023)
5.3.5 Escape Therapeutics Inc Recent Developments
5.4 Escape Therapeutics Inc
5.4.1 Escape Therapeutics Inc Profile
5.4.2 Escape Therapeutics Inc Main Business
5.4.3 Escape Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Products, Services and Solutions
5.4.4 Escape Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue (US$ Million) & (2018-2023)
5.4.5 Escape Therapeutics Inc Recent Developments
5.5 Cryo-Save AG
5.5.1 Cryo-Save AG Profile
5.5.2 Cryo-Save AG Main Business
5.5.3 Cryo-Save AG Hematopoietic Stem Cell Transplantation (HSCT) Products, Services and Solutions
5.5.4 Cryo-Save AG Hematopoietic Stem Cell Transplantation (HSCT) Revenue (US$ Million) & (2018-2023)
5.5.5 Cryo-Save AG Recent Developments
5.6 Lonza Group Ltd
5.6.1 Lonza Group Ltd Profile
5.6.2 Lonza Group Ltd Main Business
5.6.3 Lonza Group Ltd Hematopoietic Stem Cell Transplantation (HSCT) Products, Services and Solutions
5.6.4 Lonza Group Ltd Hematopoietic Stem Cell Transplantation (HSCT) Revenue (US$ Million) & (2018-2023)
5.6.5 Lonza Group Ltd Recent Developments
5.7 Pluristem Therapeutics Inc
5.7.1 Pluristem Therapeutics Inc Profile
5.7.2 Pluristem Therapeutics Inc Main Business
5.7.3 Pluristem Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Products, Services and Solutions
5.7.4 Pluristem Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue (US$ Million) & (2018-2023)
5.7.5 Pluristem Therapeutics Inc Recent Developments
5.8 ViaCord Inc
5.8.1 ViaCord Inc Profile
5.8.2 ViaCord Inc Main Business
5.8.3 ViaCord Inc Hematopoietic Stem Cell Transplantation (HSCT) Products, Services and Solutions
5.8.4 ViaCord Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue (US$ Million) & (2018-2023)
5.8.5 ViaCord Inc Recent Developments
6 North America
6.1 North America Hematopoietic Stem Cell Transplantation (HSCT) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Hematopoietic Stem Cell Transplantation (HSCT) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hematopoietic Stem Cell Transplantation (HSCT) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hematopoietic Stem Cell Transplantation (HSCT) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hematopoietic Stem Cell Transplantation (HSCT) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hematopoietic Stem Cell Transplantation (HSCT) Market Dynamics
11.1 Hematopoietic Stem Cell Transplantation (HSCT) Industry Trends
11.2 Hematopoietic Stem Cell Transplantation (HSCT) Market Drivers
11.3 Hematopoietic Stem Cell Transplantation (HSCT) Market Challenges
11.4 Hematopoietic Stem Cell Transplantation (HSCT) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
